Polyunsaturated fatty acids modify the gating of Kv channels

Frontiers in Pharmacology

Volumn 3 SEP, Issue , 2012, Pages

  Moreno, Cristina ^a   Macias, Alvaro ^a   Prieto, Angela ^a   De La Cruz, Alicia ^a   Valenzuela, Carmen ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Gating; Kv1.5; Kv11.1; n 3 PUFAs; Voltage sensor

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; POTASSIUM CHANNEL KV1.5; POTASSIUM CHANNEL KV7.1; SHAL POTASSIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ARTICLE; BINDING SITE; CHANNEL GATING; CONFORMATIONAL TRANSITION; ELECTRIC POTENTIAL; HUMAN; LIPID BILAYER; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; POTASSIUM CURRENT; PROTEIN BINDING; PROTEIN LIPID INTERACTION; TIME;

EID: 84867120774     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00163     Document Type: Article

References (88)

1. Aiyar, J., Nguyen, A. N., Chandy, K. G., and Grissmer, S. (1994). The Pregion and S6 of Kv3.1 contribute to the formation of the ion conduction pathway. Biophys. J. 67, 2261-2264.
2. Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., and Ma, J. (2002). Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346, 1113-1118.
3. Arias, C., Gonzalez, T., Moreno, I., Caballero, R., Delpon, E., Tamargo, J., and Valenzuela, C. (2003). Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels. Cardiovasc. Res. 57, 660-669.
4. Arias, C., Guizy, M., David, M., Marzian, S., Gonzalez, T., Decher, N., and Valenzuela, C. (2007). Kvβ1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels. Anesthesiol. 107, 641-651.
5. Bannenberg, G., and Serhan, C. N. (2010). Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim. Biophys. Acta 1801, 1260-1273.
6. Boland, L. M., and Drzewiecki, M. M. (2008). Polyunsaturated fatty acid modulation of voltage-gated ion channels. Cell Biochem. Biophys. 52, 59-84.
7. Boland, L. M., Drzewiecki, M. M., Timoney, G., and Casey, E. (2009). Inhibitory effects of polyunsaturated fatty acids on Kv4/KChIP potassium channels. Am. J. Physiol. Cell Physiol. 296, C1003-C1014.
8. Bond, P. J., and Sansom, M. S. (2007). Bilayer deformation by the Kv channel voltage sensor domain revealed by self-assembly simulations. Proc. Natl. Acad. Sci. U.S.A. 104, 2631-2636.
9. Brenna, J. T. (2002). Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care 5, 127-132.
10. Brock, M. W., Mathes, C., and Gilly, W. F. (2001). Selective open-channel block of Shaker (Kv1) potassium channels by s-nitrosodithiothreitol (SNDTT). J. Gen. Physiol. 118, 113-134.
11. Bruno, M. J., Koeppe, R. E., and Andersen, O. S. (2007). Docosahexaenoic acid alters bilayer elastic properties. Proc. Natl. Acad. Sci. U.S.A. 104, 9638-9643.
12. Burr, M. L., Fehily, A. M., Gilbert, J. F., Rogers, S., Holliday, R. M., Sweetnam, P. M., Elwood, P. C., and Deadman, N. M. (1989). Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2, 757-761.
13. Butterwick, J. A., and MacKinnon, R. (2010). Solution structure and phospholipid interactions of the isolated voltage-sensor domain from KvAP. J. Mol. Biol. 403, 591-606.
14. Calder, P. C. (2004). n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. 107, 1-11.
15. Choi, K. L., Mossman, C., Aube, J., and Yellen, G. (1993). The internal quaternary ammonium receptor site of shaker potassium channels. Neuron 10, 533-541.
16. David, M., Macias, A., Moreno, C., Prieto, A., Martinez-Marmol, R., Vicente, R., Felipe, A., Gonzalez, T., Tamkun, M. M., and Valenzuela, C. (2012). PKC activity regulates functional effects of KVβ1.3 on KV1.5 channels. Identification of a cardiac KV1.5 channelosome. J. Biol. Chem. 287, 21416-21428.
17. De Caterina, R., Madonna, R., Zucchi, R., and La Rovere, M. T. (2003). Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside. Am. Heart J. 146, 420-430.
18. de Lorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J. L., Monjaud, I., Guidollet, J., Touboul, P., and Delaye, J. (1994). Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343, 1454-1459.
19. Decher, N., Gonzalez, T., Streit, A. K., Sachse, F. B., Renigunta, V., Soom, M., Heinemann, S. H., Daut, J., and Sanguinetti, M. C. (2008). Structural determinants of Kvbeta1.3induced channel inactivation: a hairpin modulated by PIP2. EMBO J. 27, 3164-3174.
20. Decher, N., Kumar, P., Gonzalez, T., Pirard, B., and Sanguinetti, M. C. (2006). Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation. Mol. Pharmacol. 70, 1204-1211.
21. Decher, N., Kumar, P., Gonzalez, T., Renigunta, V., and Sanguinetti, M. C. (2005). Structural basis for competition between drug binding and Kvbeta1.3 accessory subunitinduced N-type inactivation of Kv1.5 channels. Mol. Pharmacol. 68, 995-1005.
22. Decher, N., Pirard, B., Bundis, F., Peukert, S., Baringhaus, K. H., Busch, A. E., Steinmeyer, K., and Sanguinetti, M. C. (2004). Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltagegated K+ channels. J. Biol. Chem. 279, 394-400.
23. Decher, N., Streit, A. K., Rapedius, M., Netter, M. F., Marzian, S., Ehling, P., Schlichthorl, G., Craan, T., Renigunta, V., Kohler, A., Dodel, R. C., Navarro-Polanco, R. A., PreisigMüller, R., Klebe, G., Budde, T., Baukrowitz, T., and Daut, J. (2010). RNA editing modulates the binding of drugs and highly unsaturated fatty acids to the open pore of Kv potassium channels. EMBO J. 29, 2101-2113.
24. DeCoursey, T. E. (1995). Mechanism of K+ channel block by verapamil and related compounds in rat alveolar epithelial cells. J. Gen. Physiol. 106, 745-779.
25. Den Ruijter, H. M.,Verkerk, A. O., Schumacher, C. A., Houten, S. M., Belterman, C. N., Baartscheer, A., Brouwer, I. A., van, B. M., de, R. B., and Coronel, R. (2012). A diet rich in unsaturated fatty acids prevents progression toward heart failure in a rabbit model of pressure and volume overload. Circ. Heart Fail. 5, 376-384.
26. Dobrev, D., Carlsson, L., and Nattel, S. (2012). Novel molecular targets for atrial fibrillation therapy. Nat. Rev. Drug Discov. 11, 275-291.
27. Dobrev, D., and Nattel, S. (2010). New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 375, 1212-1223.
28. Dobrev, D., and Ravens, U. (2003). Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res. Cardiol. 98, 137-148.
29. Doolan, G. K., Panchal, R. G., Fonnes, E. L., Clarke, A. L., Williams, D. A., and Petrou S. (2002). Fatty acid augmentation of the cardiac slowly activating delayed rectifier current (IKs) is conferred by hminK. FASEB J. 16, 1662-1664.
30. Dujardin, K. S., Dumotier, B., David, M., Guizy, M., Valenzuela, C., and Hondeghem, L. M. (2008). Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts. Am. J. Physiol. Heart Circ. Physiol. 295, H1414-H1421.
31. Fedida, D., Wible, B., Wang, Z., Fermini, B., Faust, F., Nattel, S., and Brown, A. M. (1993). Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ. Res. 73, 210-216.
32. Franqueza, L., Longobardo, M.,Vicente, J., Delpon, E., Tamkun, M. M., Tamargo, J., Snyders, D. J., and Valenzuela, C. (1997). Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels. Circ. Res. 81, 1053-1064.
33. Girshman, J., Greathouse, D.V., Koeppe, R. E., and Andersen, O. S. (1997). Gramicidin channels in phospholipid bilayers with unsaturated acyl chains. Biophys. J. 73, 1310-1319.
34. GISSI-Prevenzione Investigators. (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIprevenzione trial. Gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico. Lancet 354, 447-455.
35. Gonzalez, T., Arias, C., Caballero, R., Moreno, I., Delpon, E., Tamargo, J., and Valenzuela, C. (2002a). Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block. Br. J. Pharmacol. 137, 1269-1279.
36. Gonzalez, T., Navarro-Polanco, R., Arias, C., Caballero, R., Moreno, I., Delpon, E., Tamargo, J., Tamkun, M. M., and Valenzuela, C. (2002b). Assembly with the Kvβ1.3 subunit modulates drug block of hKv1.5 channels. Mol. Pharmacol. 62, 1456-1463.
37. Gubitosi-Klug, R. A., and Gross, R. W. (1996). Fatty acid ethyl esters, nonoxidative metabolites of ethanol, accelerate the kinetics of activation of the human brain delayed rectifier K+ channel,Kv1.1. J. Biol. Chem. 271, 32519-32522.
38. Guizy, M., Arias, C., David, M., Gonzalez, T., and Valenzuela, C. (2005). ω-3 and ω-6 polyunsaturated fatty acids block HERG channels. Am. J. Physiol. Cell Physiol. 289, C1251- C1260.
39. Guizy, M., David, M., Arias, C., Zhang, L., Cofan, M., Ruiz-Gutierrez, V., Ros, E., Lillo, M. P., Martens, J. R., and Valenzuela, C. (2008). Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid,alpha-linolenic acid. J. Mol. Cell Cardiol. 44, 323-335.
40. Holman, R. T. (1998). The slow discovery of the importance of omega 3 essential fatty acids in human health. J. Nutr. 128, 427S-433S.
41. Honoré, E., Barhanin, J., Attali, B., Lesage, F., and Lazdunski, M. (1994). External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids. Proc. Natl. Acad. Sci. U.S.A. 91, 1937-1941.
42. Hoopengardner, B., Bhalla, T., Staber C., and Reenan, R. (2003). Nervous system targets of RNA editing identified by comparative genomics. Science 301, 832-836.
43. Jude, S., Bedut, S., Roger, S., Pinault, M., Champeroux, P., White, E., and Le Guennec, J. Y. (2003). Peroxidation of docosahexaenoic acid is responsible for its effects on I TO and I SS in rat ventricular myocytes. Br. J. Pharmacol. 139, 816-822.
44. Jump, D. B. (2002). The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 277, 8755-8758.
45. Kass, R. S., and Moss, A. J. (2003). Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J. Clin. Invest. 112, 810-815.
46. Leaf, A., Kang, J. X., Xiao, Y. F., and Billman, G. E. (2003). Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circu- lation 107, 2646-2652.
47. Long, S. B., Campbell, E. B., and MacKinnon, R. (2005). Voltage sensor of Kv1.2: structural basis of electromechanical coupling. Science 309, 903-908.
48. Long, S. B., Tao, X., Campbell, E. B., and MacKinnon, R. (2007). Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature 450, 376-382.
49. Lopez, G. A., Jan, Y. N., and Jan, L. Y. (1994). Evidence that the S6 segment of the shaker voltage-gated K+ channel comprises part of the pore. Nature 367, 179-182.
50. Loussouarn, G., Park, K. H., Bellocq, C., Baro, I., Charpentier, F., and Escande, D. (2003). Phosphatidylinositol4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels. EMBO J. 22, 5412-5421.
51. Lundbaek, J. A. (2008). Lipid bilayermediated regulation of ion channel function by amphiphilic drugs. J. Gen. Physiol. 131, 421-429.
52. Macias, A., Moreno, C., Moral-Sanz, J., Cogolludo, A., David, M., Alemanni, M., Perez-Vizcaino, F., Zaza, A., Valenzuela, C., and Gonzalez, T. (2010). Celecoxib blocks cardiac Kv1.5, Kv4.3, and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials. J. Mol. Cell Cardiol. 49, 984-992.
53. Meves, H. (2008). Arachidonic acid and ion channels: an update. Br. J. Phar- macol. 155, 4-16.
54. Oliver, D., Lien, C. C., Soom, M., Baukrowitz, T., Jonas, P., and Fakler, B. (2004). Functional conversion between A-type and delayed rectifier K+ channels by membrane lipids. Science 304, 265-270.
55. Pandit, S. V., Berenfeld, O., Anumonwo, J. M., Zaritski, R. M., Kneller, J., Nattel, S., and Jalife, J. (2005). Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys. J. 88, 3806-3821.
56. Poling, J. S., Karanian, J. W., Salem, N. Jr., and Vicini, S. (1995). Timeand voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid. Mol. Phar- macol. 47, 381-390.
57. Roberds, S. L., and Tamkun, M. M. (1991). Cloning and tissue-specific expression of five voltage-gated potassium channel cDNAs expressed in rat heart. Proc. Natl. Acad. Sci. U.S.A. 88, 1798-1802.
58. Roden, D. M., Balser, J. R., George, A. L. Jr., and Anderson, M. E. (2002). Cardiac ion channels. Annu. Rev. Physiol. 64, 431-475.
59. Rodriguez, N., Amarouch, M. Y., Montnach, J., Piron, J., Labro, A. J., Charpentier, F., Merot, J., Baro, I., and Loussouarn, G. (2010). Phosphatidylinositol-4,5bisphosphate (PIP(2)) stabilizes the open pore conformation of the Kv11.1 (hERG) channel. Biophys. J. 99, 1110-1118.
60. Schledermann, W., Wulfsen, I., Schwarz, J. R., and Bauer, C. K. (2001). Modulation of rat erg1, erg2, erg3, and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade. J. Physiol. 532, 143-163.
61. Serhan, C. N., Yacoubian, S., and Yang, R. (2008). Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 3, 279-312.
62. Shimizu, W. (2005). The long QT syndrome: therapeutic implications of a genetic diagnosis. Cardiovasc. Res. 67, 347-356.
63. Sinclair, H. M. (1953). The diet of Canadian Indian Eskimos. Proc. Nutr. Soc. 12, 69-82.
64. Sinclair, H. M. (1956). Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet 270, 381-383.
65. Singh, R. B., Niaz, M. A., Sharma, J. P., Kumar, R., Rastogi, V., and Moshiri, M. (1997). Randomized, doubleblind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc. Drugs Ther. 11, 485-491.
66. Singleton, C. B., Valenzuela, S. M., Walker, B. D., Tie, H., Wyse, K. R., Bursill, J. A., Qiu, M. R., Breit, S. N., and Campbell, T. J. (1999). Blockade by N-3 polyunsaturated fatty acid of the Kv4.3 current stably expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 127, 941-948.
67. Smith, P. L., Baukrowitz, T., and Yellen, G. (1996). The inward rectification mechanism of the HERG cardiac potassium channel. Nature 379, 833-836.
68. Snyders, D. J., and Chaudhary, A. C. (1996). High affinity openchannel block by dofetilide of HERG, expressed in a human cell line. Mol. Pharmacol. 49, 949-955.
69. Snyders, D. J., Knoth, K. M., Roberds, S. L., and Tamkun, M. M. (1992). Time-, voltage-, and statedependent block by quinidine of a cloned human cardiac potassium channel. Mol. Pharmacol. 41, 322-330.
70. Spector, P. S., Curran, M. E., Zou, A., Keating, M. T., and Sanguinetti, M. C. (1996). Fast inactivation causes rectification of the IKr channel. J. Gen. Physiol. 107, 611-619.
71. Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., and Vincent, G. M. et al. (2000). Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102, 1178-1185.
72. Tamkun, M. M., Knoth, K. M., Walbridge, J. A., Kroemer, H., Roden, D. M., and Glover, D. M. (1991). Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle. FASEB J. 5, 331-337.
73. Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K., and Shirato, K. (2008). Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke 39, 2052-2058.
74. Tavazzi, L., Maggioni, A. P., Marchioli, R., Barlera, S., Franzosi, M. G., Latini, R., Lucci, D., Nicolosi, G. L., Porcu, M., and Tognoni, G. (2008). Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 1223-1230.
75. Thomas, D., Kiehn, J., Katus, H. A., and Karle, C. A. (2003). Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing. Cardiovasc. Res. 60, 235-241.
76. Valenzuela, C., Delpon, E., Franqueza, L., Gay, P., Perez, O., Tamargo, J., and Snyders, D. J. (1996). Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation 94, 562-570.
77. Valenzuela, C., Delpon, E., Tamkun, M. M., Tamargo, J., and Snyders, D. J. (1995). Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaineenantiomers. Biophys. J. 69, 418-427.
78. Varro, A., Biliczki, P., Iost, N., Virag, L., Hala, O., Kovacs, P., Matyus, P., and Papp, J. G. (2004). Theoretical possibilities for the development of novel antiarrhythmic drugs. Curr. Med. Chem. 11, 1-11.
79. Verkerk, A. O., van Ginneken, A. C., Berecki, G., Den Ruijter, H. M., Schumacher, C.A.,Veldkamp, M.W., Baartscheer, A., Casini, S., Opthof, T., Hovenier, R., Fiolet, J. W., Zock, P. L., and Coronel, R. (2006). Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc. Res. 70, 509-520.
80. Wettwer, E. (2007). Is there a functional correlate of Kv1.5 in the ventricle of canine heart and what would it mean for the use of I(Kur) blockers? Br. J. Pharmacol. 152, 835-837.
81. Wettwer, E., Hala, O., Christ, T., Heubach, J. F., Dobrev, D., Knaut, M.,Varro, A., and Ravens, U. (2004). Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circula- tion 110, 2299-2306.
82. Xiao, Y. F., Gomez, A. M., Morgan, J. P., Lederer, W. J., and Leaf, A. (1997). Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U.S.A. 94, 4182-4187.
83. Xiao, Y. F., Kang, J. X., Morgan, J. P., and Leaf, A. (1995). Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 11000-11004.
84. Xiao, Y. F., Ke, Q., Wang, S. Y., Auktor, K., Yang, Y., Wang, G. K., Morgan, J. P., and Leaf, A. (2001). Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit NaC chan-nels. Proc. Natl. Acad. Sci. U.S.A. 98, 3606-3611.
85. Xiao, Y. F., Wright, S. N., Wang, G. K., Morgan, J. P., and Leaf, A. (2000). Coexpression with beta(1)-subunit modifies the kinetics and fatty acid block of hH1(alpha) Na(+) channels. Am. J. Physiol. Heart Circ. Physiol. 279, H35-H46.
86. Xu, X., Jiang, M., Wang, Y., Smith, T., Baumgarten, C. M., Wood, M. A., and Tseng, G. N. (2010). Long-term fish oil supplementation induces cardiac electrical remodeling by changing channel protein expression in the rabbit model. PLoS. ONE. 5, e10140. doi:10.1371/journal.pone.0010140
87. Yeola, S. W., Rich, T. C., Uebele, V. N., Tamkun, M. M., and Snyders, D. J. (1996). Molecular analysis of a binding site for quinidine in a human cardiac delayed rectifier K+ channel. Role of S6 in antiarrhythmic drug binding. Circ. Res. 78, 1105-1114.
88. Zhang, S., Rajamani, S., Chen, Y., Gong, Q.,Rong,Y.,Zhou,Z.,Ruoho,A.,and January,C. T. (2001). Cocaine blocks HERG, but not KvLQT1+ minK potassium channels. Mol. Pharmacol. 59, 1069-1076.